首页 > 最新文献

Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii最新文献

英文 中文
A Case of Medullary Carcinoma of the Jejunum Combined with the Intestinal Lymphangiectasia Accompanied by the Malabsorption Syndrome 空肠髓样癌合并肠淋巴管扩张伴吸收不良综合征1例
Q3 Medicine Pub Date : 2023-10-31 DOI: 10.22416/1382-4376-2023-33-4-92-100
O. A. Lobanova, D. S. Trusova, M. A. Afonina, V. E. Varentsoy, D. D. Protsenko, N. V. Kretova, N. B. Serezhnikova, M. A. Peshkova, N. V. Zharkov, S. E. Kochetkova, Yu. Yu. Stepanova, Z. D. Shtanev, K. A. Vekhova, V. A. Yumasheva, A. O. Kolesnikova, M. Akan, M. O. Chanturiya, T. V. Serebrov, A. S. Tertychnyy, H. Guski, E. E. Rudenko, T. A. Demura, E. A. Kogan
Aim: to present a clinical and morphological observation of an extremely rare combination of medullary carcinoma of the jejunum and intestinal lymphangiectasia in a 33-year-old patient with clinical features of malabsorption syndrome over the 10 years. Key points. An autopsy revealed a tumor formation spreading from the wall of the jejunum to the mesentery, with metastases to the mesenteric lymph nodes. The medullary carcinoma with positive expression of СD117, DOG1, EMA, PanCK, PDL-1, vimentin, mosaic non-intense expression of CA19-9, calretinin, CD10, CDX2, CEA, MUC-5AC, SATB2, and negative reaction to ALK, CD3, CD8, CD20, CD30, CD31, CD34, CD45, CD56, chromogranin, CK7, CK20, desmin. The proliferative index was high: Ki-67 > 80 %. Moreover, during the histological examination of the intestinal wall, intestinal lymphangiectasia complicated by the malabsorption syndrome was revealed. Conclusion. The uniqueness of this clinical and morphological case is in the combination of medullary carcinoma of the jejunum metastasized to the mesenteric lymph nodes with the underlying intestinal lymphangiectasia accompanied by the development of malabsorption syndrome.
目的:对一例以吸收不良综合征为临床特征的33岁患者进行临床和形态学观察,观察其10年来极为罕见的空肠髓样癌合并肠淋巴管扩张。要点。尸检显示肿瘤从空肠壁扩散到肠系膜,并转移到肠系膜淋巴结。骨髓癌СD117、DOG1、EMA、PanCK、PDL-1、vimentin阳性表达,CA19-9、calretinin、CD10、CDX2、CEA、MUC-5AC、SATB2嵌合不强烈表达,ALK、CD3、CD8、CD20、CD30、CD31、CD34、CD45、CD56、chromogranin、CK7、CK20、desmin阴性表达。增殖指数高:Ki-67;80%。肠壁组织学检查显示肠淋巴管扩张合并吸收不良综合征。结论。本病例临床和形态学的独特之处在于空肠髓样癌转移到肠系膜淋巴结,并伴有潜在的肠淋巴管扩张,并伴有吸收不良综合征的发展。
{"title":"A Case of Medullary Carcinoma of the Jejunum Combined with the Intestinal Lymphangiectasia Accompanied by the Malabsorption Syndrome","authors":"O. A. Lobanova, D. S. Trusova, M. A. Afonina, V. E. Varentsoy, D. D. Protsenko, N. V. Kretova, N. B. Serezhnikova, M. A. Peshkova, N. V. Zharkov, S. E. Kochetkova, Yu. Yu. Stepanova, Z. D. Shtanev, K. A. Vekhova, V. A. Yumasheva, A. O. Kolesnikova, M. Akan, M. O. Chanturiya, T. V. Serebrov, A. S. Tertychnyy, H. Guski, E. E. Rudenko, T. A. Demura, E. A. Kogan","doi":"10.22416/1382-4376-2023-33-4-92-100","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-92-100","url":null,"abstract":"Aim: to present a clinical and morphological observation of an extremely rare combination of medullary carcinoma of the jejunum and intestinal lymphangiectasia in a 33-year-old patient with clinical features of malabsorption syndrome over the 10 years. Key points. An autopsy revealed a tumor formation spreading from the wall of the jejunum to the mesentery, with metastases to the mesenteric lymph nodes. The medullary carcinoma with positive expression of СD117, DOG1, EMA, PanCK, PDL-1, vimentin, mosaic non-intense expression of CA19-9, calretinin, CD10, CDX2, CEA, MUC-5AC, SATB2, and negative reaction to ALK, CD3, CD8, CD20, CD30, CD31, CD34, CD45, CD56, chromogranin, CK7, CK20, desmin. The proliferative index was high: Ki-67 > 80 %. Moreover, during the histological examination of the intestinal wall, intestinal lymphangiectasia complicated by the malabsorption syndrome was revealed. Conclusion. The uniqueness of this clinical and morphological case is in the combination of medullary carcinoma of the jejunum metastasized to the mesenteric lymph nodes with the underlying intestinal lymphangiectasia accompanied by the development of malabsorption syndrome.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"145 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern Possibilities of Using Lactulose in Clinical Practice 乳果糖在临床应用中的现代可能性
Q3 Medicine Pub Date : 2023-10-31 DOI: 10.22416/1382-4376-2023-33-4-70-75
A. A. Sheptulin
Aim of the publication. To present an overview of current literature data on the possibilities of application of lactulose in clinical practice. Key findings . Lactulose is a synthetic disaccharide belonging to the class of osmotic laxatives. Officially permitted indications for its appointment in Russian Federation are functional constipation (including in children, the elderly and senile, pregnant women and women in postpartum period), an obstipation type of irritable bowel syndrome, the need to soften the consistency of feces in hemorrhoids and anal fissures, after operations on the colon and anorectal area, as well as hepatic encephalopathy. Other indications include preparation for colonoscopy, treatment and prevention of disorders of the intestinal microbiota, prevention of constipation in oncological patients receiving narcotic analgesics, as well as patients on artificial lung ventilation. Conclusion . Lactulose is a highly effective and safe drug, which combines osmotic laxative effect with expressed prebiotic action and is used in a wide clinical practice.
出版的目的。概述当前文献资料的可能性应用乳果糖在临床实践。主要发现。乳果糖是一种人工合成的双糖,属于渗透性泻药。俄罗斯联邦官方允许的任命适应症是功能性便秘(包括儿童、老年人和老年人、孕妇和产后妇女)、顽固性肠易激综合征、需要软化痔疮和肛裂粪便的稠度、结肠和肛肠区手术后以及肝性脑病。其他适应症包括结肠镜检查前的准备、肠道菌群紊乱的治疗和预防、接受麻醉性镇痛药物的肿瘤患者以及人工肺通气患者的便秘预防。结论。乳果糖是一种高效、安全的药物,具有渗透通便作用和表达益生元作用,在临床中得到广泛应用。
{"title":"Modern Possibilities of Using Lactulose in Clinical Practice","authors":"A. A. Sheptulin","doi":"10.22416/1382-4376-2023-33-4-70-75","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-70-75","url":null,"abstract":"Aim of the publication. To present an overview of current literature data on the possibilities of application of lactulose in clinical practice. Key findings . Lactulose is a synthetic disaccharide belonging to the class of osmotic laxatives. Officially permitted indications for its appointment in Russian Federation are functional constipation (including in children, the elderly and senile, pregnant women and women in postpartum period), an obstipation type of irritable bowel syndrome, the need to soften the consistency of feces in hemorrhoids and anal fissures, after operations on the colon and anorectal area, as well as hepatic encephalopathy. Other indications include preparation for colonoscopy, treatment and prevention of disorders of the intestinal microbiota, prevention of constipation in oncological patients receiving narcotic analgesics, as well as patients on artificial lung ventilation. Conclusion . Lactulose is a highly effective and safe drug, which combines osmotic laxative effect with expressed prebiotic action and is used in a wide clinical practice.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"42 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion 实践方面的临床表现、发病机理和治疗酒精性肝病和非酒精脂肪肝:专家的意见
Q3 Medicine Pub Date : 2023-10-26 DOI: 10.22416/1382-4376-2023-33-4-7-13
V. V. Tsukanov, M. F. Osipenko, E. V. Beloborodova, M. A. Livzan, I. B. Khlynov, S. A. Alekseenko, Yu. P. Sivolap, J. L. Tonkikh, A. V. Vasyutin
Aim: to present the results of an expert discussion of modern aspects of the clinical manifestations, pathogenesis and treatment of alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Key points. ALD and NAFLD are characterized by high prevalence and have a significant impact on public health. For the diagnosis of liver pathology, it is important to determine the stage of fibrosis and the severity of the exacerbation of the disease. In the treatment of ALD, it is recommended to achieve abstinence, proper nutrition, the appointment of B vitamins, drugs with cytoprotective activity. In severe hepatitis, corticosteroids may be prescribed. In the treatment of NAFLD, diet and lifestyle modification, weight loss, the use of insulin sensitizers, vitamin E, statins (in the presence of hyperlipidemia) and drugs with metabolic activity are effective. Currently, a point of view is being actively expressed about the synergism of the action of alcohol and the metabolic syndrome on the development of fibrosis, cirrhosis, and hepatocellular carcinoma. The current international consensus recommends a change in the nomenclature of NAFLD and ALD and proposes the terms “metabolically associated steatotic liver disease” and “metabolically associated alcoholic liver disease”. Conclusion. The closeness of the clinical manifestations and pathogenesis of NAFLD and ALD justifies attention to drugs with metabolic activity, which are recommended by the Russian Gastroenterological Association and Russian Scientific Liver Society for the treatment of these diseases. The experts support the suggestion to quantify alcohol consumption in patients with NAFLD in order to change the management of patients, if necessary.
目的:介绍酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)的临床表现、发病机制和治疗的现代专家讨论结果。要点。ALD和NAFLD的特点是患病率高,对公众健康有重大影响。对于肝脏病理的诊断,确定纤维化的分期和疾病恶化的严重程度是很重要的。在治疗ALD时,建议做到节制,适当营养,预约B族维生素,具有细胞保护活性的药物。对于严重肝炎,可开皮质类固醇。在NAFLD的治疗中,饮食和生活方式的改变、体重减轻、胰岛素增敏剂、维生素E、他汀类药物(在高脂血症存在时)和具有代谢活性的药物的使用是有效的。目前,关于酒精和代谢综合征在纤维化、肝硬化和肝细胞癌发展中的协同作用的观点正在被积极表达。目前的国际共识建议改变NAFLD和ALD的命名,并建议使用“代谢相关脂肪变性肝病”和“代谢相关酒精性肝病”这两个术语。结论。NAFLD和ALD的临床表现和发病机制的密切性证明了对具有代谢活性的药物的关注,俄罗斯胃肠病学协会和俄罗斯科学肝脏学会推荐这些药物用于治疗这些疾病。专家们支持量化NAFLD患者酒精摄入量的建议,以便在必要时改变患者的管理。
{"title":"Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion","authors":"V. V. Tsukanov, M. F. Osipenko, E. V. Beloborodova, M. A. Livzan, I. B. Khlynov, S. A. Alekseenko, Yu. P. Sivolap, J. L. Tonkikh, A. V. Vasyutin","doi":"10.22416/1382-4376-2023-33-4-7-13","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-7-13","url":null,"abstract":"Aim: to present the results of an expert discussion of modern aspects of the clinical manifestations, pathogenesis and treatment of alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Key points. ALD and NAFLD are characterized by high prevalence and have a significant impact on public health. For the diagnosis of liver pathology, it is important to determine the stage of fibrosis and the severity of the exacerbation of the disease. In the treatment of ALD, it is recommended to achieve abstinence, proper nutrition, the appointment of B vitamins, drugs with cytoprotective activity. In severe hepatitis, corticosteroids may be prescribed. In the treatment of NAFLD, diet and lifestyle modification, weight loss, the use of insulin sensitizers, vitamin E, statins (in the presence of hyperlipidemia) and drugs with metabolic activity are effective. Currently, a point of view is being actively expressed about the synergism of the action of alcohol and the metabolic syndrome on the development of fibrosis, cirrhosis, and hepatocellular carcinoma. The current international consensus recommends a change in the nomenclature of NAFLD and ALD and proposes the terms “metabolically associated steatotic liver disease” and “metabolically associated alcoholic liver disease”. Conclusion. The closeness of the clinical manifestations and pathogenesis of NAFLD and ALD justifies attention to drugs with metabolic activity, which are recommended by the Russian Gastroenterological Association and Russian Scientific Liver Society for the treatment of these diseases. The experts support the suggestion to quantify alcohol consumption in patients with NAFLD in order to change the management of patients, if necessary.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"169 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134972560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophageal Lichen Planus as a Cause of Dysphagia: Literature Review and Clinical Observation 食管扁平苔藓是导致吞咽困难的原因:文献回顾和临床观察
Q3 Medicine Pub Date : 2023-10-26 DOI: 10.22416/1382-4376-2023-33-4-76-84
A. I. Dolgushina, E. R. Olevskaya, A. O. Khikhlova, A. A. Saenko, S. U. Belousov
Aim: to analyze the literature data, and to raise awareness of doctors of various specialties about the methods of diagnosis and treatment of esophageal lichen planus (ELP). Key points. In a 67-year-old female patient with complaints of difficulty swallowing solid food and weight loss, esophagogastroduodenoscopy revealed subcompensated stenosis of the middle third of the esophagus and signs of fibrinous esophagitis. Based on the characteristics of the endoscopic picture and the detection of apoptotic Ciwatt bodies in esophageal biopsies, a diagnosis of ELP was established. Treatment with glucocorticosteroids led to relief of symptoms and positive endoscopic dynamics. ELP is rare and the least studied, data on this disease in the literature are presented mainly in the form of clinical observations and analysis of series of cases. Typical clinical manifestations include dysphagia and odynophagia. Despite the low prevalence, ELP can be associated with serious complications: stenosis and esophageal squamous cell carcinoma. Endoscopic examination reveals characteristic signs in the esophagus: swelling, thickening and increased vulnerability of the mucosa, often with fibrin, formation of membranes and strictures. The histological picture is represented by epithelial dyskeratosis with exfoliation, lichenoid lymphocytic infiltration. The most specific histological sign is the presence of apoptotic Civatte bodies. Recommendations for the treatment of ELP are limited to the results of a series of clinical observations and include the prescription of systemic corticosteroids. The issue of supportive therapy is the least studied. Conclusion. Analysis of the literature data and the clinical case demonstrate that lichen planus of the esophagus is one of the rare causes of dysphagia. Characteristic endoscopic and histological signs are key for the diagnosis. The management of patients with esophageal lichen planus is insufficiently defined and today includes taking of glucocorticosteroids, endoscopic dilation of stricture and dynamic endoscopic observation, given the high risk of squamous cell carcinoma in this category of patients.
目的:分析文献资料,提高各专科医生对食管扁平苔藓(ELP)的诊断和治疗方法的认识。要点。一位67岁的女性患者,主诉吞咽固体食物困难,体重减轻,食管胃十二指肠镜检查显示食管中间三分之一的亚代偿性狭窄和纤维性食管炎的征象。根据内镜下图像的特点和食管活检中凋亡的Ciwatt小体的检测,建立ELP的诊断。治疗与糖皮质激素导致缓解症状和积极的内窥镜动力学。ELP是一种罕见且研究最少的疾病,文献中关于该病的资料主要以临床观察和系列病例分析的形式呈现。典型临床表现为吞咽困难和吞咽困难。尽管发病率较低,但ELP可伴有严重并发症:狭窄和食管鳞状细胞癌。内镜检查显示食道特征性征象:粘膜肿胀、增厚、易损性增加,常伴有纤维蛋白、膜形成和狭窄。组织学表现为上皮性角化不良伴脱落、地衣样淋巴细胞浸润。最特异的组织学征象是存在凋亡的Civatte小体。ELP的治疗建议仅限于一系列临床观察的结果,包括全身性皮质类固醇的处方。支持性治疗的问题是研究最少的。结论。文献资料和临床病例分析表明,食道扁平苔藓是引起吞咽困难的罕见原因之一。内镜和组织学特征是诊断的关键。食管扁平苔藓患者的治疗方法尚不明确,考虑到这类患者鳞状细胞癌的高风险,目前包括服用糖皮质激素、内镜下狭窄扩张和动态内镜下观察。
{"title":"Esophageal Lichen Planus as a Cause of Dysphagia: Literature Review and Clinical Observation","authors":"A. I. Dolgushina, E. R. Olevskaya, A. O. Khikhlova, A. A. Saenko, S. U. Belousov","doi":"10.22416/1382-4376-2023-33-4-76-84","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-76-84","url":null,"abstract":"Aim: to analyze the literature data, and to raise awareness of doctors of various specialties about the methods of diagnosis and treatment of esophageal lichen planus (ELP). Key points. In a 67-year-old female patient with complaints of difficulty swallowing solid food and weight loss, esophagogastroduodenoscopy revealed subcompensated stenosis of the middle third of the esophagus and signs of fibrinous esophagitis. Based on the characteristics of the endoscopic picture and the detection of apoptotic Ciwatt bodies in esophageal biopsies, a diagnosis of ELP was established. Treatment with glucocorticosteroids led to relief of symptoms and positive endoscopic dynamics. ELP is rare and the least studied, data on this disease in the literature are presented mainly in the form of clinical observations and analysis of series of cases. Typical clinical manifestations include dysphagia and odynophagia. Despite the low prevalence, ELP can be associated with serious complications: stenosis and esophageal squamous cell carcinoma. Endoscopic examination reveals characteristic signs in the esophagus: swelling, thickening and increased vulnerability of the mucosa, often with fibrin, formation of membranes and strictures. The histological picture is represented by epithelial dyskeratosis with exfoliation, lichenoid lymphocytic infiltration. The most specific histological sign is the presence of apoptotic Civatte bodies. Recommendations for the treatment of ELP are limited to the results of a series of clinical observations and include the prescription of systemic corticosteroids. The issue of supportive therapy is the least studied. Conclusion. Analysis of the literature data and the clinical case demonstrate that lichen planus of the esophagus is one of the rare causes of dysphagia. Characteristic endoscopic and histological signs are key for the diagnosis. The management of patients with esophageal lichen planus is insufficiently defined and today includes taking of glucocorticosteroids, endoscopic dilation of stricture and dynamic endoscopic observation, given the high risk of squamous cell carcinoma in this category of patients.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"12 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134972559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate Results of Colonic Flat Epithelial Neoplasms Removal Using Diathermic Snare Endoscopic Mucosal Resection and Mucosectomy Combined with Dissection in the Submucosal Layer: Comparative Assessment 透热圈套内镜下粘膜切除术与粘膜切除术联合粘膜下层夹层切除结肠扁平上皮肿瘤的即时效果:比较评估
Q3 Medicine Pub Date : 2023-10-08 DOI: 10.22416/1382-4376-2023-33-4-14-23
A. A. Fedorenko, P. V. Pavlov, A. P. Kiryukhin, A. S. Tertychnyy
Aim: to compare the immediate outcomes of removing colonic flat epithelial neoplasms by using diathermic snare endoscopic mucosal resection (EMR) and mucosectomy with endoscopic submucosal dissection (ESD). Materials and methods. Ninety-six endoscopic procedures were conducted on the colon of 93 patients with flat epithelial neoplasms. The mean age of patients was 64.9 ± 10.7 years, with an age range of 39 to 88 years. The size range of epithelial neoplasms was 20 to 70 mm, with a median of 37.4 ± 14.8 mm. Only patients with benign epithelial neoplasms were included in the study since patients with suspected malignancy in laterally spreading tumors are indicated for ESD intervention to avoid fragmentary excision and risk of colorectal cancer progression due to possible positive resection margins. The patients were separated into two equally sized groups and treated with EMR and ESD methods. Results. Epithelial neoplasms in the ESD group had an average size of 41.6 ± 15 mm while those in the EMR group had an average size of 33.1 ± 13.5 mm. The ESD group had an average intervention time of 143.6 ± 102.9 min, whereas the EMR group had an average intervention time of 52.6 ± 34.4 min. Both groups (96 adenomas) had a total of 10 (10.4 %) patients who experienced colonic perforations during the intervention, with 4 (4.1 %) cases observed in the EMR group and 6 (6.2 %) in the ESD group. No statistically significant differences were identified in the occurrence of perforations during the operation ( p = 0.7401). ESD resulted in an en bloc removal rate of 44/48 (91.6 %), whereas EMR only achieved a rate of 14/48 (29.1 %). Conclusion. Endoscopic mucosectomy with submucosal dissection (ESD), in contrast to endoscopic mucosal resection (EMR) with diathermic snare, provides a higher frequency of tumor removal en bloc, regardless of tumor size, but is characterized by a longer duration of intervention ( p < 0.0001). In the ESD group, there were twice as many intraoperative bleedings ( p = 0.0061) due to the longer duration and technical complexity of the procedure. There were no statistically significant differences in the incidence of late complications between the groups ( p = 0.9999). Local recurrence of adenoma developed in two patients (4.1 %) after pEMR, statistically significant differences were noted ( p < 0.0006).
目的:比较透热陷阱内镜下粘膜切除术(EMR)与内镜下粘膜夹层切除术(ESD)切除结肠扁平上皮肿瘤的即时疗效。材料和方法。我们对93例扁平上皮肿瘤患者的结肠进行了96次内镜检查。患者平均年龄64.9±10.7岁,年龄范围39 ~ 88岁。上皮肿瘤的大小范围为20 ~ 70 mm,中位数为37.4±14.8 mm。本研究仅纳入良性上皮肿瘤患者,因为一侧扩散肿瘤疑似恶性的患者需要进行ESD干预,以避免碎片性切除,避免因切除边缘可能呈阳性而导致结直肠癌进展的风险。将患者分为大小相等的两组,分别采用EMR和ESD方法治疗。结果。ESD组上皮肿瘤平均大小为41.6±15 mm, EMR组上皮肿瘤平均大小为33.1±13.5 mm。ESD组的平均干预时间为143.6±102.9 min,而EMR组的平均干预时间为52.6±34.4 min。两组(96个腺瘤)共10例(10.4%)患者在干预期间出现结肠穿孔,其中EMR组4例(4.1%),ESD组6例(6.2%)。术中穿孔发生率差异无统计学意义(p = 0.7401)。ESD的整体去除率为44/48(91.6%),而EMR仅为14/48(29.1%)。结论。内镜下粘膜剥离(ESD)粘膜切除术与内镜下粘膜切除(EMR)与透热陷阱相比,无论肿瘤大小如何,都能提供更高的整体肿瘤切除频率,但其特点是干预时间更长(p <0.0001)。在ESD组中,由于手术时间更长和技术复杂,术中出血是前者的两倍(p = 0.0061)。两组患者晚期并发症发生率比较,差异无统计学意义(p = 0.9999)。2例患者(4.1%)在pEMR后发生腺瘤局部复发,差异有统计学意义(p <0.0006)。
{"title":"Immediate Results of Colonic Flat Epithelial Neoplasms Removal Using Diathermic Snare Endoscopic Mucosal Resection and Mucosectomy Combined with Dissection in the Submucosal Layer: Comparative Assessment","authors":"A. A. Fedorenko, P. V. Pavlov, A. P. Kiryukhin, A. S. Tertychnyy","doi":"10.22416/1382-4376-2023-33-4-14-23","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-14-23","url":null,"abstract":"Aim: to compare the immediate outcomes of removing colonic flat epithelial neoplasms by using diathermic snare endoscopic mucosal resection (EMR) and mucosectomy with endoscopic submucosal dissection (ESD). Materials and methods. Ninety-six endoscopic procedures were conducted on the colon of 93 patients with flat epithelial neoplasms. The mean age of patients was 64.9 ± 10.7 years, with an age range of 39 to 88 years. The size range of epithelial neoplasms was 20 to 70 mm, with a median of 37.4 ± 14.8 mm. Only patients with benign epithelial neoplasms were included in the study since patients with suspected malignancy in laterally spreading tumors are indicated for ESD intervention to avoid fragmentary excision and risk of colorectal cancer progression due to possible positive resection margins. The patients were separated into two equally sized groups and treated with EMR and ESD methods. Results. Epithelial neoplasms in the ESD group had an average size of 41.6 ± 15 mm while those in the EMR group had an average size of 33.1 ± 13.5 mm. The ESD group had an average intervention time of 143.6 ± 102.9 min, whereas the EMR group had an average intervention time of 52.6 ± 34.4 min. Both groups (96 adenomas) had a total of 10 (10.4 %) patients who experienced colonic perforations during the intervention, with 4 (4.1 %) cases observed in the EMR group and 6 (6.2 %) in the ESD group. No statistically significant differences were identified in the occurrence of perforations during the operation ( p = 0.7401). ESD resulted in an en bloc removal rate of 44/48 (91.6 %), whereas EMR only achieved a rate of 14/48 (29.1 %). Conclusion. Endoscopic mucosectomy with submucosal dissection (ESD), in contrast to endoscopic mucosal resection (EMR) with diathermic snare, provides a higher frequency of tumor removal en bloc, regardless of tumor size, but is characterized by a longer duration of intervention ( p < 0.0001). In the ESD group, there were twice as many intraoperative bleedings ( p = 0.0061) due to the longer duration and technical complexity of the procedure. There were no statistically significant differences in the incidence of late complications between the groups ( p = 0.9999). Local recurrence of adenoma developed in two patients (4.1 %) after pEMR, statistically significant differences were noted ( p < 0.0006).","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135252331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-Stage Treatment of Enterocutaneous Fistulas 肠皮瘘的两阶段治疗
Q3 Medicine Pub Date : 2023-09-29 DOI: 10.22416/1382-4376-2023-33-4-58-69
V. Yu. Struchkov, S. V. Berelavichus, E. A. Akhtanin, D. S. Gorin, M. V. Dvukhzhilov, A. A. Goev, A. I. Burmistrov, P. V. Markov, A. G. Kriger
Aim: to determine the most efficient treatment of enterocutaneous fistulas. Materials and methods. Eighty-eight patients with intestinal fistulas underwent a two-stage treatment, including: the first stage — multicomponent therapy, the second stage — reconstructive surgery. Enterocutaneous fistulas were diagnosed in 61 patients, enteroatmospheric fistulas — in 26 patients, and combined fistula (enterocutaneous and enteroatmospheric) — in 1 patient. Results. All 88 patients underwent reconstructive surgery after the multicomponent therapy. Resection of the intestine with a fistula with the formation of an entero-entero anastomosis was performed in 72 (81.8 %) patients; marginal resection of the intestine with a fistula, followed by suturing of the defect — in 7 (8.0 %); resection of the intestine with fistulas in combination with excision and suturing of the fistula — in 5 (5.7 %); an operation aimed at disabling the fistula from the passage of intestinal contents — in 3 (3.4 %); resection of the intestine with a fistula in combination with fistula exclusion — in 1 (1.1 %) patient. Postoperative complications in the group of patients with enteroatmospheric fistulas occurred in 13 cases, in the group with enterocutaneous fistulas — in 25 patients. Three (3.4 %) patients with enterocutaneous fistulas died from complications unrelated to the underlying disease and surgical interventions. Conclusion. Two-stage treatment including multicomponent therapy (nutritional support, infection generalization control, local wound treatment) and reconstructive surgery allowed to reduce mortality rates to 3.4 %, which proves the effectiveness of this method.
目的:探讨肠皮瘘最有效的治疗方法。材料和方法。88例肠瘘患者接受了两阶段的治疗,包括:第一阶段-多组分治疗,第二阶段-重建手术。61例诊断为肠外瘘,26例诊断为肠外瘘,1例诊断为肠外瘘和肠外瘘。结果。88例患者均在多组分治疗后接受了重建手术。72例(81.8%)患者行肠瘘切除并形成肠-肠吻合术;边缘切除肠瘘,然后缝合缺损- 7例(8.0%);肠管切除合并瘘管切除缝合5例(5.7%);一项旨在使瘘管无法通过肠道内容物的手术- 3例(3.4%);1例(1.1%)患者行肠内瘘管切除合并瘘管排除术。肠大气瘘组术后并发症13例,肠皮肤瘘组术后并发症25例。3例(3.4%)肠皮瘘患者死于与基础疾病和手术干预无关的并发症。结论。两阶段治疗包括多组分治疗(营养支持、感染综合控制、局部伤口治疗)和重建手术,使死亡率降至3.4%,证明了该方法的有效性。
{"title":"Two-Stage Treatment of Enterocutaneous Fistulas","authors":"V. Yu. Struchkov, S. V. Berelavichus, E. A. Akhtanin, D. S. Gorin, M. V. Dvukhzhilov, A. A. Goev, A. I. Burmistrov, P. V. Markov, A. G. Kriger","doi":"10.22416/1382-4376-2023-33-4-58-69","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-58-69","url":null,"abstract":"Aim: to determine the most efficient treatment of enterocutaneous fistulas. Materials and methods. Eighty-eight patients with intestinal fistulas underwent a two-stage treatment, including: the first stage — multicomponent therapy, the second stage — reconstructive surgery. Enterocutaneous fistulas were diagnosed in 61 patients, enteroatmospheric fistulas — in 26 patients, and combined fistula (enterocutaneous and enteroatmospheric) — in 1 patient. Results. All 88 patients underwent reconstructive surgery after the multicomponent therapy. Resection of the intestine with a fistula with the formation of an entero-entero anastomosis was performed in 72 (81.8 %) patients; marginal resection of the intestine with a fistula, followed by suturing of the defect — in 7 (8.0 %); resection of the intestine with fistulas in combination with excision and suturing of the fistula — in 5 (5.7 %); an operation aimed at disabling the fistula from the passage of intestinal contents — in 3 (3.4 %); resection of the intestine with a fistula in combination with fistula exclusion — in 1 (1.1 %) patient. Postoperative complications in the group of patients with enteroatmospheric fistulas occurred in 13 cases, in the group with enterocutaneous fistulas — in 25 patients. Three (3.4 %) patients with enterocutaneous fistulas died from complications unrelated to the underlying disease and surgical interventions. Conclusion. Two-stage treatment including multicomponent therapy (nutritional support, infection generalization control, local wound treatment) and reconstructive surgery allowed to reduce mortality rates to 3.4 %, which proves the effectiveness of this method.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135343636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma PNPLA3&lt;/i&gt;非酒精性脂肪性肝病、肝硬化和肝细胞癌患者的I148M基因多态性
Q3 Medicine Pub Date : 2023-09-19 DOI: 10.22416/1382-4376-2023-33-4-30-37
V. V. Petkau, G. A. Tsaur, E. N. Bessonova, A. A. Karimova
Aim: to determine the frequency of PNPLA3 rs738409 C>G gene polymorphism, leading to p .I148M substitution, in patients with non-alcoholic fatty liver disease (NAFLD), and to reveal the association between polymorphism and probable NAFLD outcomes: liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Materials and methods. The study was conducted according to the “case-control” design, three main groups were formed: a group with NAFLD ( n = 46), a group with LC ( n = 61), a group with HCC ( n = 50), as well as a control group ( n = 70), for all groups we performed genotyping of the rs738409 polymorphism of the PNPLA3 gene. The relationship between the occurrence of different genotype variants and the diagnosis of patients was evaluated, the odds ratio (OR) of progression of NAFLD and the reliability of intergroup differences were determined. Results. NAFLD patients with PNPLA3 I148M polymorphism have a significantly higher chance of developing LC and HCC. The odds ratio for the GG genotype was 7.94 (95 % Cl: 2.19–28.84; p = 0.030) for LC and 6.51 (95 % Cl: 1.15–4.08; p = 0.039) — for HCC with concomitant LC. The presence of the minor G allele also increases the likelhood of transition from NAFLD to LC (OR = 2.38; 95 % Cl: 1.41–4.02; p = 0.010) and HCC in the presence of cirrhosis (OR = 2.17; 95 % Cl: 1.15–4.08; p = 0.039). Differences in the frequency of PNPLA3 polymorphism between the NAFLD and HCC groups were not significant. Additional risk factors for HCC associated with NAFLD are overweight (OR = 5.14; 95 % Cl: 1.94–13.67; p < 0.001), arterial hypertension (OR = 8.49; 95 % Cl: 3.05–23,62; p < 0.001) and diabetes mellitus (OR = 8.57; 95 % Cl: 1.03–71.48; p = 0.032). Conclusion. The frequency of single nucleotide polymorphism PNPLA3 significantly differs in patients with NAFLD, cirrhosis and HCC compared with the control group of healthy volunteers. The PNPLA3 I148M polymorphism increases the incidence of NAFLD progression to cirrhosis and HCC, but only with concomitant cirrhosis.
目的:确定非酒精性脂肪性肝病(NAFLD)患者PNPLA3 rs738409 C>G基因多态性导致p . i148m替代的频率,并揭示多态性与NAFLD可能结局(肝硬化(LC)和肝细胞癌(HCC))之间的关系。材料和方法。本研究采用“病例-对照”设计,主要分为NAFLD组(n = 46)、LC组(n = 61)、HCC组(n = 50)和对照组(n = 70),对所有组进行PNPLA3基因rs738409多态性基因分型。评估不同基因型变异的发生与患者诊断的关系,确定NAFLD进展的优势比(OR)及组间差异的可靠性。结果。pnpla3i148m多态性的NAFLD患者发生LC和HCC的几率明显增高。GG基因型的优势比为7.94 (95% Cl: 2.19 ~ 28.84;LC的p = 0.030)和6.51 (95% Cl: 1.15-4.08;p = 0.039) - HCC合并LC。G等位基因的存在也增加了NAFLD向LC转变的可能性(OR = 2.38;95% Cl: 1.41-4.02;p = 0.010)和HCC合并肝硬化(OR = 2.17;95% Cl: 1.15-4.08;P = 0.039)。PNPLA3多态性在NAFLD和HCC组之间的频率差异无统计学意义。HCC与NAFLD相关的其他危险因素是超重(OR = 5.14;95% Cl: 1.94-13.67;p & lt;0.001),动脉高血压(OR = 8.49;95% Cl: 3.05 - 23,62;p & lt;0.001)和糖尿病(OR = 8.57;95% Cl: 1.03-71.48;P = 0.032)。结论。NAFLD、肝硬化和HCC患者单核苷酸多态性PNPLA3的频率与健康志愿者对照组相比有显著差异。PNPLA3 I148M多态性增加NAFLD进展为肝硬化和HCC的发生率,但仅伴有肝硬化。
{"title":"Research of &lt;i&gt;PNPLA3&lt;/i&gt; I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma","authors":"V. V. Petkau, G. A. Tsaur, E. N. Bessonova, A. A. Karimova","doi":"10.22416/1382-4376-2023-33-4-30-37","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-30-37","url":null,"abstract":"Aim: to determine the frequency of PNPLA3 rs738409 C>G gene polymorphism, leading to p .I148M substitution, in patients with non-alcoholic fatty liver disease (NAFLD), and to reveal the association between polymorphism and probable NAFLD outcomes: liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Materials and methods. The study was conducted according to the “case-control” design, three main groups were formed: a group with NAFLD ( n = 46), a group with LC ( n = 61), a group with HCC ( n = 50), as well as a control group ( n = 70), for all groups we performed genotyping of the rs738409 polymorphism of the PNPLA3 gene. The relationship between the occurrence of different genotype variants and the diagnosis of patients was evaluated, the odds ratio (OR) of progression of NAFLD and the reliability of intergroup differences were determined. Results. NAFLD patients with PNPLA3 I148M polymorphism have a significantly higher chance of developing LC and HCC. The odds ratio for the GG genotype was 7.94 (95 % Cl: 2.19–28.84; p = 0.030) for LC and 6.51 (95 % Cl: 1.15–4.08; p = 0.039) — for HCC with concomitant LC. The presence of the minor G allele also increases the likelhood of transition from NAFLD to LC (OR = 2.38; 95 % Cl: 1.41–4.02; p = 0.010) and HCC in the presence of cirrhosis (OR = 2.17; 95 % Cl: 1.15–4.08; p = 0.039). Differences in the frequency of PNPLA3 polymorphism between the NAFLD and HCC groups were not significant. Additional risk factors for HCC associated with NAFLD are overweight (OR = 5.14; 95 % Cl: 1.94–13.67; p < 0.001), arterial hypertension (OR = 8.49; 95 % Cl: 3.05–23,62; p < 0.001) and diabetes mellitus (OR = 8.57; 95 % Cl: 1.03–71.48; p = 0.032). Conclusion. The frequency of single nucleotide polymorphism PNPLA3 significantly differs in patients with NAFLD, cirrhosis and HCC compared with the control group of healthy volunteers. The PNPLA3 I148M polymorphism increases the incidence of NAFLD progression to cirrhosis and HCC, but only with concomitant cirrhosis.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135109470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokines in Liver Cirrhosis (Their Importance in Assessing Activity and Decompensation) 肝硬化中的细胞因子(在评估活动和失代偿中的重要性)
Q3 Medicine Pub Date : 2023-09-13 DOI: 10.22416/1382-4376-2023-33-4-24-29
G. K. Mirodzhov, S. D. Pulatova
Aim: studying the role of pro-inflammatory and anti-inflammatory cytokines in the pathogenesis of liver cirrhosis progression. Materials and methods. The material of the study was the data of clinical-instrumental, biochemical, virological studies of 109 patients with liver cirrhosis of various etiologty, who were hospitalized in the clinic of the Institute of Gastroenterology (Dushanbe, Republic of Tajikistan). The diagnosis of the underlying disease was established according to the clinical recommendations of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association for the diagnosis and treatment of liver fibrosis and cirrhosis and their complications (2021); decompensated liver cirrhosis was established according to the 1996 Child — Pugh classification. The age of the patients ranged from 17 to 79 years (36.9 ± 0.8 years), there were 55 men and 54 women. Results. Among the examined patients, compensated liver cirrhosis (Class A) according to Child — Pugh was detected in 18 persons, subcompensated (Class B) — in 14, decompensated (Class C) — in 77. The study of the content of pro-inflammatory and anti-inflammatory cytokines in the blood serum of patients with Class A liver cirrhosis showed, that levels of tumour necrosis factor alpha (TNF-α), interleukin-2, interleukin-6 were statistically higher compared to healthy individuals, while the concentration of anti-inflammatory interleukin-10 was lower (30.7 ± 4.7 pg/mL) in comparison with the control group. In patients with Class B liver cirrhosis, the level of TNF-α increased to 75.0 ± 4.5 pg/mL ( p < 0.001), interleukin-2 — to 328.7 ± 23.9 pg/mL ( p < 0.05), and interleukin-6 — to 95.4 ± 7.7 pg/mL ( p < 0.001). Serum interleukin-10 decreased compared with the control group (23.1 ± 2.8 pg/mL; p > 0.05). At the decompensated stage of Class C cirrhosis, a huge release of pro-inflammatory cytokines occurs — the content of TNF-α increases by 80 times, of interleukin-2 — by more than 60 times, аs for interleukin-10, its content is progressively reduced. Conclusion. In liver cirrhosis, there is a significant disruption in the synthesis of pro-inflammatory cytokines, which is manifested by a sharp increase in the content of TNF-α, interleukin-2 and interleukin-6. High levels of proinflammatory cytokines in blood serum in liver cirrhosis correlate with the activity and degree of decompensation, which indicates their important role in the pathogenesis and progression of the pathological process.
目的:探讨促炎和抗炎细胞因子在肝硬化发病机制中的作用。材料和方法。该研究的材料是109名不同病因的肝硬化患者的临床仪器、生化和病毒学研究数据,这些患者在塔吉克斯坦共和国杜尚别胃肠病学研究所的诊所住院。基础疾病的诊断是根据俄罗斯肝脏研究学会和俄罗斯胃肠病学协会关于肝纤维化和肝硬化及其并发症的诊断和治疗的临床建议确定的(2021年);失代偿性肝硬化是根据1996年Child - Pugh分类建立的。患者年龄17 ~ 79岁(36.9±0.8岁),男性55例,女性54例。结果。在检查的患者中,根据Child - Pugh, 18人发现代偿性肝硬化(A类),14人发现亚代偿性肝硬化(B类),77人发现失代偿性肝硬化(C类)。对A类肝硬化患者血清中促炎和抗炎细胞因子含量的研究表明,肿瘤坏死因子α (TNF-α)、白细胞介素-2、白细胞介素-6水平与健康人群相比均有统计学意义升高,而抗炎白细胞介素-10浓度与对照组相比有统计学意义降低(30.7±4.7 pg/mL)。B级肝硬化患者TNF-α水平升高至75.0±4.5 pg/mL (p <0.001),白细胞介素-2降至328.7±23.9 pg/mL (p <0.05),白细胞介素-6降至95.4±7.7 pg/mL (p <0.001)。血清白介素-10较对照组降低(23.1±2.8 pg/mL;p比;0.05)。在C类肝硬化失代偿期,促炎细胞因子大量释放,TNF-α含量增加80倍,白细胞介素-2含量增加60倍以上,白细胞介素-10含量逐渐降低。结论。在肝硬化中,促炎细胞因子的合成明显中断,表现为TNF-α、白细胞介素-2、白细胞介素-6含量急剧升高。肝硬化患者血清中促炎细胞因子的高水平与失代偿的活性和程度相关,提示其在肝硬化病理过程的发病和进展中起着重要作用。
{"title":"Cytokines in Liver Cirrhosis (Their Importance in Assessing Activity and Decompensation)","authors":"G. K. Mirodzhov, S. D. Pulatova","doi":"10.22416/1382-4376-2023-33-4-24-29","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-24-29","url":null,"abstract":"Aim: studying the role of pro-inflammatory and anti-inflammatory cytokines in the pathogenesis of liver cirrhosis progression. Materials and methods. The material of the study was the data of clinical-instrumental, biochemical, virological studies of 109 patients with liver cirrhosis of various etiologty, who were hospitalized in the clinic of the Institute of Gastroenterology (Dushanbe, Republic of Tajikistan). The diagnosis of the underlying disease was established according to the clinical recommendations of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association for the diagnosis and treatment of liver fibrosis and cirrhosis and their complications (2021); decompensated liver cirrhosis was established according to the 1996 Child — Pugh classification. The age of the patients ranged from 17 to 79 years (36.9 ± 0.8 years), there were 55 men and 54 women. Results. Among the examined patients, compensated liver cirrhosis (Class A) according to Child — Pugh was detected in 18 persons, subcompensated (Class B) — in 14, decompensated (Class C) — in 77. The study of the content of pro-inflammatory and anti-inflammatory cytokines in the blood serum of patients with Class A liver cirrhosis showed, that levels of tumour necrosis factor alpha (TNF-α), interleukin-2, interleukin-6 were statistically higher compared to healthy individuals, while the concentration of anti-inflammatory interleukin-10 was lower (30.7 ± 4.7 pg/mL) in comparison with the control group. In patients with Class B liver cirrhosis, the level of TNF-α increased to 75.0 ± 4.5 pg/mL ( p < 0.001), interleukin-2 — to 328.7 ± 23.9 pg/mL ( p < 0.05), and interleukin-6 — to 95.4 ± 7.7 pg/mL ( p < 0.001). Serum interleukin-10 decreased compared with the control group (23.1 ± 2.8 pg/mL; p > 0.05). At the decompensated stage of Class C cirrhosis, a huge release of pro-inflammatory cytokines occurs — the content of TNF-α increases by 80 times, of interleukin-2 — by more than 60 times, аs for interleukin-10, its content is progressively reduced. Conclusion. In liver cirrhosis, there is a significant disruption in the synthesis of pro-inflammatory cytokines, which is manifested by a sharp increase in the content of TNF-α, interleukin-2 and interleukin-6. High levels of proinflammatory cytokines in blood serum in liver cirrhosis correlate with the activity and degree of decompensation, which indicates their important role in the pathogenesis and progression of the pathological process.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135786787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echinococcal Cyst Blockade — the Rare Cause of Acute Pancreatitis and Obstructive Jaundice 包虫病囊肿阻断-急性胰腺炎和梗阻性黄疸的罕见病因
Q3 Medicine Pub Date : 2023-09-13 DOI: 10.22416/1382-4376-2023-33-4-85-91
S. A. Budzinskiy, S. G. Shapovaliants, R. V. Plakhov, M. V. Murashkina, E. A. Vorobyeva, D. R. Berdieva, P. V. Usyaky, E. D. Fedorov
Aim: demonstrate an algorithm for the diagnosis and treatment of acute pancreatitis and obstructive jaundice caused by obstruction of the terminal part of the common bile duct by daughter echinococcal cyst. Key points. The article presents a clinical case of acute echinococcal obstruction of the terminal part of the common bile duct in a patient with a complicated course of liver echinococcosis. A 33-year-old man was hospitalized with epigastrium and right hypochondrium pains and jaundice. In 2019 the patient underwent the removal of a cyst in the 7th liver segment and cholecystectomy for liver and gallbladder echinococcal lesions. Laboratory research revealed leukocytosis, hyperbilirubinemia and an increase in the transaminases level. Transabdominal ultrasound showed signs of dilatation throughout bile ducts. Duodenoscopy revealed a fixed yellowish-white oval formation with transluent capsule, completely blocking bile and pancreatic juice outflow at the major duodenal papilla. After non-annulation endoscopic papillotomy, migration of the substrate (echinococcal cyst) into the duodenum was noted, active flow of bile and pancreatic secretions was restored. Oral transpapillary cholangioscopy was performed for a detailed bile ducts examination. It revealed no echinococcal cysts, residual parasitic structures or biliary tree lesions. The treatment was completed with pancreatic stenting. After complex treatment in the intensive care and surgery unit with complete condition stabilization, the patient was discharged with recommendations for further treatment in a specialized clinic. Conclusion. Migration of a daughter cyst from the echinococcal liver focus can cause acute blockade of the terminal part of the common bile duct and acute obstructive pancreatitis. The combination of clinical, radiological and endoscopic methods allows to diagnose and eliminate this rare complication of liver echinococcosis with subsequent successful treatment.
目的:提出一种诊断和治疗子棘球蚴囊肿阻塞胆总管末端引起的急性胰腺炎和梗阻性黄疸的算法。要点。本文报道一例肝包虫病并发肝包虫病患者急性包虫病梗阻胆总管末端的临床病例。一名33岁男子因上腹部和右胁肋疼痛和黄疸住院。2019年,患者因肝胆包虫病接受了第7肝段囊肿切除术和胆囊切除术。实验室研究显示白细胞增多、高胆红素血症和转氨酶水平升高。经腹超声显示胆管扩张的迹象。十二指肠镜显示一个固定的黄白色卵形物,有透明的被膜,完全阻断了十二指肠主要乳头处的胆汁和胰液流出。非环形内镜下乳头切除术后,发现底物(棘球蚴囊肿)迁移到十二指肠,胆汁和胰腺分泌物恢复活跃流动。经口经乳头胆管镜检查详细胆管检查。检查未发现棘球蚴囊肿、残留寄生结构或胆道病变。治疗以胰腺支架置入术完成。在重症监护室和外科病房接受复杂治疗后,病情完全稳定,患者出院,并建议在专科诊所进一步治疗。结论。子囊从包虫病肝灶转移可引起胆总管末端急性阻塞和急性梗阻性胰腺炎。结合临床、放射学和内镜方法,可以诊断和消除这种罕见的肝包虫病并发症,并随后成功治疗。
{"title":"Echinococcal Cyst Blockade — the Rare Cause of Acute Pancreatitis and Obstructive Jaundice","authors":"S. A. Budzinskiy, S. G. Shapovaliants, R. V. Plakhov, M. V. Murashkina, E. A. Vorobyeva, D. R. Berdieva, P. V. Usyaky, E. D. Fedorov","doi":"10.22416/1382-4376-2023-33-4-85-91","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-4-85-91","url":null,"abstract":"Aim: demonstrate an algorithm for the diagnosis and treatment of acute pancreatitis and obstructive jaundice caused by obstruction of the terminal part of the common bile duct by daughter echinococcal cyst. Key points. The article presents a clinical case of acute echinococcal obstruction of the terminal part of the common bile duct in a patient with a complicated course of liver echinococcosis. A 33-year-old man was hospitalized with epigastrium and right hypochondrium pains and jaundice. In 2019 the patient underwent the removal of a cyst in the 7th liver segment and cholecystectomy for liver and gallbladder echinococcal lesions. Laboratory research revealed leukocytosis, hyperbilirubinemia and an increase in the transaminases level. Transabdominal ultrasound showed signs of dilatation throughout bile ducts. Duodenoscopy revealed a fixed yellowish-white oval formation with transluent capsule, completely blocking bile and pancreatic juice outflow at the major duodenal papilla. After non-annulation endoscopic papillotomy, migration of the substrate (echinococcal cyst) into the duodenum was noted, active flow of bile and pancreatic secretions was restored. Oral transpapillary cholangioscopy was performed for a detailed bile ducts examination. It revealed no echinococcal cysts, residual parasitic structures or biliary tree lesions. The treatment was completed with pancreatic stenting. After complex treatment in the intensive care and surgery unit with complete condition stabilization, the patient was discharged with recommendations for further treatment in a specialized clinic. Conclusion. Migration of a daughter cyst from the echinococcal liver focus can cause acute blockade of the terminal part of the common bile duct and acute obstructive pancreatitis. The combination of clinical, radiological and endoscopic methods allows to diagnose and eliminate this rare complication of liver echinococcosis with subsequent successful treatment.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135786788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Morphological Features of Dysplasia and Early Gastric Cancer in the Patients with Autoimmune Gastritis 自身免疫性胃炎患者不典型增生和早期胃癌的临床和形态学特征
Q3 Medicine Pub Date : 2023-09-11 DOI: 10.22416/1382-4376-2023-33-3-16-33
A. S. Tertychnyy, N. V. Pachuashvili, D. P. Nagornaya, T. L. Lapina, E. A. Losik, A. B. Ponomarev, P. V. Pavlov, A. P. Kiryukhin, A. A. Fedorenko, D. D. Protsenko, V. T. Ivashkin
А im: to analyze a series of cases of dysplasia and early gastric cancer developed in patients with autoimmune gastritis (AIG), and to identify their clinical and morphological features. Materials and methods. The study included six cases of detection of early gastric cancer on the background of AIG. Four out of six patients underwent endoscopic treatment, and in three out of six cases patients underwent endoscopic mucosectomy with dissection in the submucosal layer. One patient underwent endoscopic surgery in 2017, he continues annual dynamic follow-up without signs of tumour recurrence. A female patient with type 1 neuroendocrine tumour and mild dysplasia is awaiting treatment. Results. In five out of six patients with AIG, the localization of lesions prevailed in the stomach body, while all detected tumours were early ones, and according to the immunophenotype — of a gastric type. The presented cases of tumours were not accompanied by hyperplasia of neuroendocrine cells directly in the area of the tumour itself, but only in the surrounding gastric mucosa. Additionally, several cases of early gastrointestinal stromal tumours were found, which were characterized by low proliferative activity and had small sizes. Conclusion. The predominance of pseudopyloric metaplasia in the surrounding mucosa allows us to consider pseudopyloric metaplasia as a potentially significant change in the gastric mucosa of patients with AIG that may precede the development of gastric cancer.
А im:分析自身免疫性胃炎(AIG)患者发生的一系列不典型增生和早期胃癌的病例,探讨其临床和形态学特征。材料和方法。本研究包括6例在AIG背景下发现的早期胃癌。6例患者中有4例接受了内镜治疗,6例患者中有3例接受了内镜粘膜切除术并剥离粘膜下层。1例患者于2017年接受内窥镜手术,每年进行动态随访,无肿瘤复发迹象。1型神经内分泌肿瘤和轻度发育不良的女性患者正在等待治疗。结果。在6例AIG患者中,有5例病变定位于胃体,而所有检测到的肿瘤都是早期肿瘤,并且根据胃型的免疫表型。本病例的肿瘤不伴有神经内分泌细胞的增生,直接在肿瘤本身的区域,但仅在周围的胃粘膜。此外,还发现了几例早期胃肠道间质瘤,其特点是增殖活性低,体积小。结论。假幽门化生在周围粘膜中的优势使我们认为假幽门化生可能是AIG患者胃粘膜的一个潜在的显著变化,可能先于胃癌的发展。
{"title":"Clinical and Morphological Features of Dysplasia and Early Gastric Cancer in the Patients with Autoimmune Gastritis","authors":"A. S. Tertychnyy, N. V. Pachuashvili, D. P. Nagornaya, T. L. Lapina, E. A. Losik, A. B. Ponomarev, P. V. Pavlov, A. P. Kiryukhin, A. A. Fedorenko, D. D. Protsenko, V. T. Ivashkin","doi":"10.22416/1382-4376-2023-33-3-16-33","DOIUrl":"https://doi.org/10.22416/1382-4376-2023-33-3-16-33","url":null,"abstract":"А im: to analyze a series of cases of dysplasia and early gastric cancer developed in patients with autoimmune gastritis (AIG), and to identify their clinical and morphological features. Materials and methods. The study included six cases of detection of early gastric cancer on the background of AIG. Four out of six patients underwent endoscopic treatment, and in three out of six cases patients underwent endoscopic mucosectomy with dissection in the submucosal layer. One patient underwent endoscopic surgery in 2017, he continues annual dynamic follow-up without signs of tumour recurrence. A female patient with type 1 neuroendocrine tumour and mild dysplasia is awaiting treatment. Results. In five out of six patients with AIG, the localization of lesions prevailed in the stomach body, while all detected tumours were early ones, and according to the immunophenotype — of a gastric type. The presented cases of tumours were not accompanied by hyperplasia of neuroendocrine cells directly in the area of the tumour itself, but only in the surrounding gastric mucosa. Additionally, several cases of early gastrointestinal stromal tumours were found, which were characterized by low proliferative activity and had small sizes. Conclusion. The predominance of pseudopyloric metaplasia in the surrounding mucosa allows us to consider pseudopyloric metaplasia as a potentially significant change in the gastric mucosa of patients with AIG that may precede the development of gastric cancer.","PeriodicalId":33798,"journal":{"name":"Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136025587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1